General Information
| Application | Inhibitor |
|---|
| Description | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively. |
|---|
| Cas NO. | 231277-92-2 |
|---|
| Purity | ≥99% |
|---|---|
| Molecular Weight | 581.06 |
| Formula | C29H26ClFN4O4S |
| Solubility |
DMSO : 100 mg/mL Ethanol : Insoluble Water : Insoluble |
|---|
| Target / IC50 |
ErbB2 : 9.2 nM ErbB4 : 367 nM EGFR : 10.8 nM |
|---|
| Storage |
Powder : -20°C for 3 years |
|---|
| Alias | N/A |
|---|
|
|
1 mg |
5 mg |
10 mg |
|
|
1 mM |
1.7210 mL | 8.6050 mL | 17.2099 mL | |
| 5 mM | 0.3442 mL | 1.7210 mL | 3.4420 mL | |
| 10 mM | 0.1721 mL | 0.8605 mL | 1.7210 mL | |
.png)